latest update:
[TrialBase DB]

trial summary · NCT07869641

Improved Breast Enlargement Using the Subject's Own Fat Tissue

Structural Fat Grafting (SFG) With Improved Fat Transplantation

Trial record from the TrialBase DB dataset, status RECRUITING, condition Breast Augmentation, sponsored by 4Tissue. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07869641phase —enrollment 20start 2026-11

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

The goal of this clinical study is to learn if the Medical Device Under Investigation (simply "the device") is safe to use in human adults undergoing breast augmentation surgery. The study will also show if the device can improve volume retention of the breast after the surgery. In the study, breast augmentation surgery will be done by transplanting the participant's own fatty tissue from the belly or buttocks to the breast. This surgical technique is also known as Structural Fat Grafting (SFG). The main questions this clinical study aims to answer is: * Is the use of the device safe in human? * Is the device fully degraded over time? * Does the use of the device during SFG improve breast volume retention, compared to standard SFG without the device. Thereto, 20 healthy female participants between the age of 18 and 55 years old will be included in this study. Half of the participants (10 out of 20) will undergo the surgery with the use of the device (treatment group) and the other 10 participants will undergo the surgery without the use of the device (control group). Participants will be followed up for 6 months after the surgery, with a possible extension to 9 months, and visit the hospital 6 to 7 times for checkups and tests.

Source record: https://clinicaltrials.gov/study/NCT07869641

Facts

registry idNCT07869641
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionBreast Augmentation
sponsor4Tissue
sponsor classINDUSTRY
enrollment20
start date2026-11
primary completion2027-04
completion2027-12
results postednot reported

Conditions

  • Breast Augmentation

Interventions

  • An injectable, biodegradable hydrogel, in reconstitution medium
  • Reconstitution medium

Countries

  • Belgium

Intervention types: DEVICE

Work with this record